Outset Medical

$39.03 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Outset Medical

Outset Medical, Inc. is a medical technology company. The Company offers Tablo, a dialysis machine. Tablo offers acute and chronic dialysis. Tablo produces dialysate that’s customized to the patient’s prescription. Its touchscreen guidance and animated instructions enables to train new users. Tablo has integrated water purification and produces dialysis on demand. The other features of Tablo include integrated blood pressure cuff and automated saline bolus and tracking. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to a single platform from the hospital to the home. The three subtypes of hemodialysis that are used in the hospital are Intermittent Hemodialysis (IHD), Slow Low Efficiency Dialysis (SLED) and CRRT. IHD is used at the bedside or an inpatient dialysis unit outside of the ICU, while SLED and CRRT are used in the ICU.

Stock Analysis

last close $40.92
1-mo return -10.2%
3-mo return -26.8%
avg daily vol. 355.37T
52-week high 66.96
52-week low 39.77
market cap. $1.9B
forward pe -
annual div. -
roe -
ltg forecast -91.1%
dividend yield -
annual rev. $66M
inst own. 92.1%
baraka

Subscribe now for daily local and international financial news

Subscribe